# A Clinical Study of GZR33 and GZR101 in Healthy Subjects

> **NCT06556641** · PHASE1 · COMPLETED · sponsor: **Gan and Lee Pharmaceuticals, USA** · enrollment: 28 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** GZR33 Injection
- **DRUG:** GZR101 Injection
- **DRUG:** Placebo
- **DRUG:** Insulin Degludec

## Key facts

- **NCT ID:** NCT06556641
- **Lead sponsor:** Gan and Lee Pharmaceuticals, USA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-17
- **Primary completion:** 2023-02-03
- **Final completion:** 2023-02-03
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2024-08-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06556641

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06556641, "A Clinical Study of GZR33 and GZR101 in Healthy Subjects". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06556641. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*